GeneraMedix Inc. is a pharmaceutical company that develops, markets and distributes generic injectable products. nnThe company's MissionnnThe company aims to bring to market generic products where the active pharmaceutical ingredient is difficult to source, manufacturing or regulatory hurdles exist and are difficult to overcome, or where product is in short supply. n
Missing: GeneraMedix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: GeneraMedix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
GeneraMedix Frequently Asked Questions (FAQ)
Where is GeneraMedix's headquarters?
GeneraMedix's headquarters is located at 150 Allen Road, Liberty Corner.
Who are GeneraMedix's competitors?
Competitors of GeneraMedix include Novast Pharmaceuticals, Adello Biologics, GC-Rise Pharmaceutical, Scientific Protein Laboratories, ANI Pharmaceuticals and 11 more.
Compare GeneraMedix to Competitors
InnoZen, Inc. discovers, develops, and markets, or out licenses, over-the-counter (OTC) health products that fulfill unmet consumer need. InnoZen developed a oral strip to deliver drug active ingredients. This technology is currently being used in new Chloraseptic' Relief Strips' and has many potential applications in both the human and veterinary markets.
Heritage Pharmaceuticals Inc. is a rapidly growingngeneric pharmaceutical company engaged in thenacquisition, licensing, development, marketing,nsale and distribution of generic pharmaceuticalnproducts for the global prescriptionndrug markets.n nHeritage has established itself as a competitor in thengeneric pharmaceutical industry by initially targetingnniche products with revenues that are generally toonsmall to command the resources and attention ofnmajor market participants. Heritage launched its U.S. label in 2006 and has rapidly built a portfolio of highnquality multi-source generic pharmaceutical productsnacross multiple therapeutic categories, including: ncardiovascular, pain management, anti-infectives andnmetabolic disease.n nThe company's business model aims to utilize strategicnoutsourcing to U.S.F.D.A. qualified manufacturingnand development organizations in both NorthnAmerica and Asia. The Company will continuento introduce its new generic products during 2008nfollowing its tradition quality, value andnservice in generics.
Savior Lifetec is engaged in the development & manufacture of high quality sterile API (Active Pharmaceutical Ingredients) especially carbapenem antibiotics for generic drug markets.
Indena is a company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and cosmetics industries. Indena, a privately owned Italian company, has around 700 employees, including 10% dedicated to full-time research, aims to manage cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. The phyto-chemical research is carried out in Indena's own Research Center in Settala, Italy. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. One of the main strategic objectives of the research is the development of new active principles for pharmaceutical applications. This is also an indispensable base for the health-food and cosmetics industries. In the pharmaceutical sector Indena is currently focusing on the development of anti-cancer treatments, following the successes of paclitaxel, as well as on anti-microbial and on anti-viral drugs. Also under study are active principles for the treatment of pathologies and dysfunction of the central nervous system, such as depression, anxiety, impotence, sleep disorders, and algesia. Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.
Fada Pharma is Argentina's leading manufacturer of generic pharmaceuticals for the institutional market
Axis Pharmaceutical Packaging has developed a high-quality, high-speed, pharmaceutical solid dose medication bottle filling machine that meets industry and FDA standards.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.